Author: Richard Goldstein

Last month, a judge recommended that a former University of Kansas Medical Center professor be banned from Federal U.S. funding for two years. The ban came after an investigation showed that the researcher, Rakesh Srivastava, had submitted a grant application that was heavily plagiarized from someone else’s. But there’s far more to the case, as Richard Goldstein –who represented the scientist in Bois v. HHS, the first case to overturn a funding ban by the U.S. Office of Research Integrity (ORI), and who has written about another case for us — argues in this guest post. 

Picture this scenario: You submit an NIH grant proposal.  Unbeknownst to you, it contains material plagiarized from another scientist.  Are you liable for research misconduct? Continue reading A colleague included plagiarized material in your grant proposal. Are you liable?

Retraction Watch readers may have followed our coverage of the case of Christian Kreipke, a former Wayne State researcher who was recently barred from U.S. Federal funding for five years. That punishment followed years of allegations and court cases, along with half a dozen retractions. The case has been complicated, to say the least, and led to a 126-page decision by a judge last month. Here, Boston-based attorney Richard Goldstein, who represented the scientist in Bois v. HHS, the first case to overturn a funding ban by the U.S. Office of Research Integrity (ORI), tries to explain what it could all mean.

Can you commit research misconduct if you fail to detect false data from another scientist? Continue reading Are you liable for misconduct by scientific collaborators? What a recent court decision could mean for scientists